Penpulimab, identified by the unique CAS number 2350298-92-7, represents a emerging medicinal antibody currently undergoing assessment for its potential in malignancy treatment. This pharmaceutical agent is designed to target a defined mechanism involved in cancerous progression. Early information suggest it exhibits significant efficacy and is … Read More

S2H97 Antibody: A Valuable Resource for SARS-CoV-2 Research This S2H97 antibody is a essential resource for accelerating understanding regarding SARS-CoV-2. The antibody's function to specifically bind to the viral spike glycoprotein makes it highly advantageous for various applications, like assessment with the virus, blocking infecti… Read More